|
1
|
Maimela NR, Liu S and Zhang Y: Fates of
CD8+ T cells in tumor microenvironment. Comput Struct Biotechnol J.
17:1–13. 2019. View Article : Google Scholar
|
|
2
|
Locati M, Curtale G and Mantovani A:
Diversity, mechanisms, and significance of macrophage plasticity.
Annu Rev Pathol. 15:123–147. 2020. View Article : Google Scholar
|
|
3
|
Goswami KK, Ghosh T, Ghosh S, Sarkar M,
Bose A and Baral R: Tumor promoting role of anti-tumor macrophages
in tumor microenvironment. Cell Immunol. 316:1–10. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang XM, Chen DG, Li SC, Zhu B and Li ZJ:
Embryonic origin and subclonal evolution of tumor-associated
macrophages imply preventive care for cancer. Cells. 10:9032021.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang H, Yung MMH, Ngan HYS, Chan KKL and
Chan DW: The impact of the tumor microenvironment on macrophage
polarization in cancer metastatic progression. Int J Mol Sci.
22:65602021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yahaya MAF, Lila MAM, Ismail S, Zainol M
and Afizan N: Tumour-associated macrophages (TAMs) in colon cancer
and how to reeducate them. J Immunol Res. 2019:23682492019.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Castegna A, Gissi R, Menga A, Montopoli M,
Favia M, Viola A and Canton M: Pharmacological targets of
metabolism in disease: Opportunities from macrophages. Pharmacol
Ther. 210:1075212020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chanmee T, Ontong P, Konno K and Itano N:
Tumor-associated macrophages as major players in the tumor
microenvironment. Cancers (Basel). 6:1670–1690. 2014. View Article : Google Scholar
|
|
9
|
Liu Q, Li Y, Niu Z, Zong Y, Wang M, Yao L,
Lu Z, Liao Q and Zhao Y: Atorvastatin (Lipitor) attenuates the
effects of aspirin on pancreatic cancerogenesis and the
chemotherapeutic efficacy of gemcitabine on pancreatic cancer by
promoting M2 polarized tumor associated macrophages. J Exp Clin
Cancer Res. 35:332016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Singhal S, Stadanlick J, Annunziata MJ,
Rao AS, Bhojnagarwala PS, O'Brien S, Moon EK, Cantu E,
Danet-Desnoyers G, Ra HJ, et al: Human tumor-associated
monocytes/macrophages and their regulation of T cell responses in
early-stage lung cancer. Sci Transl Med. 11:eaat15002019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gyori D, Lim EL, Grant FM, Spensberger D,
Roychoudhuri R, Shuttleworth SJ, Okkenhaug K, Stephens LR and
Hawkins PT: Compensation between CSF1R+ macrophages and Foxp3+ Treg
cells drives resistance to tumor immunotherapy. JCI Insight.
3:e1206312018. View Article : Google Scholar :
|
|
12
|
Cassetta L and Pollard JW: Targeting
macrophages: Therapeutic approaches in cancer. Nat Rev Drug Discov.
17:887–904. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Wang W, Wu H, Zhou Y, Qin X, Wang
Y, Wu J, Sun XY, Yang Y, Xu H, et al: The essential role of PRAK in
tumor metastasis and its therapeutic potential. Nat Commun.
12:17362021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fu LQ, Du WL, Cai MH, Yao JY, Zhao YY and
Mou XZ: The roles of tumor-associated macrophages in tumor
angiogenesis and metastasis. Cell Immunol. 353:1041192020.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou Z, Xia G, Xiang Z, Liu M, Wei Z, Yan
J, Chen W, Zhu J, Awasthi N, Sun X, et al: A C-X-C chemokine
receptor type 2-dominated cross-talk between tumor cells and
macrophages drives gastric cancer metastasis. Clin Cancer Res.
25:3317–3328. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pastushenko I and Blanpain C: EMT
transition states during tumor progression and metastasis. Trends
Cell Biol. 29:212–226. 2019. View Article : Google Scholar
|
|
17
|
Paolillo M and Schinelli S: Extracellular
matrix alterations in metastatic processes. Int J Mol Sci.
20:49472019. View Article : Google Scholar :
|
|
18
|
Li W, Zhang X, Wu F, Zhou Y, Bao Z, Li H,
Zheng P and Zhao S: Gastric cancer-derived mesenchymal stromal
cells trigger M2 macrophage polarization that promotes metastasis
and EMT in gastric cancer. Cell Death Dis. 10:9182019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Swierczak A and Pollard JW: Myeloid cells
in metastasis. Cold Spring Harb Perspect Med. 10:a0380262020.
View Article : Google Scholar
|
|
20
|
Zavyalova MV, Denisov EV, Tashireva LA,
Savelieva OE, Kaigorodova EV, Krakhmal NV and Perelmuter VM:
Intravasation as a key step in cancer metastasis. Biochemistry
(Mosc). 84:762–772. 2019. View Article : Google Scholar
|
|
21
|
Wang J, Cao Z, Zhang XM, Nakamura M, Sun
M, Hartman J, Harris RA, Sun Y and Cao Y: Novel mechanism of
macrophage-mediated metastasis revealed in a zebrafish model of
tumor development. Cancer Res. 75:306–315. 2015. View Article : Google Scholar
|
|
22
|
Chen XW, Yu TJ, Zhang J, Li Y, Chen HL,
Yang GF, Yu W, Liu YZ, Liu XX, Duan CF, et al: CYP4A in
tumor-associated macrophages promotes pre-metastatic niche
formation and metastasis. Oncogene. 36:5045–5057. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ludwig N, Yerneni SS, Azambuja JH,
Gillespie DG, Menshikova EV, Jackson EK and Whiteside TL:
Tumor-derived exosomes promote angiogenesis via adenosine
A2B receptor signaling. Angiogenesis. 23:599–610. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Min AKT, Mimura K, Nakajima S, Okayama H,
Saito K, Sakamoto W, Fujita S, Endo H, Saito M, Saze Z, et al:
Therapeutic potential of anti-VEGF receptor 2 therapy targeting for
M2-tumor-associated macrophages in colorectal cancer. Cancer
Immunol Immunother. 70:289–298. 2021. View Article : Google Scholar
|
|
25
|
Dong F, Ruan S, Wang J, Xia Y, Le K, Xiao
X, Hu T and Wang Q: M2 macrophage-induced lncRNA PCAT6 facilitates
tumorigenesis and angiogenesis of triple-negative breast cancer
through modulation of VEGFR2. Cell Death Dis. 11:7282020.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang B, Li Q, Wang J, Zhao S, Nashun B,
Qin L and Chen X: Plasmodium infection inhibits tumor angiogenesis
through effects on tumor-associated macrophages in a murine
implanted hepatoma model. Cell Commun Signal. 18:1572020.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Anderson NM and Simon MC: The tumor
microenvironment. Curr Biol. 30:R921–R925. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fu T, Dai LJ, Wu SY, Xiao Y, Ma D, Jiang
YZ and Shao ZM: Spatial architecture of the immune microenvironment
orchestrates tumor immunity and therapeutic response. J Hematol
Oncol. 14:982021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kirkiles-Smith NC, Harding MJ, Shepherd
BR, Fader SA, Yi T, Wang Y, McNiff JM, Snyder EL, Lorber MI,
Tellides G and Pober JS: Development of a humanized mouse model to
study the role of macrophages in allograft injury. Transplantation.
87:189–197. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Comito G, Giannoni E, Segura CP,
Barcellos-de-Souza P, Raspollini MR, Baroni G, Lanciotti M, Serni S
and Chiarugi P: Cancer-associated fibroblasts and M2-polarized
macrophages synergize during prostate carcinoma progression.
Oncogene. 33:2423–2431. 2014. View Article : Google Scholar
|
|
32
|
Yang F, Wei Y, Han D, Li Y, Shi S, Jiao D,
Wu J, Zhang Q, Shi C, Yang L, et al: Interaction with CD68 and
Regulation of GAS6 expression by endosialin in fibroblasts drives
recruitment and polarization of macrophages in hepatocellular
carcinoma. Cancer Res. 80:3892–3905. 2020.PubMed/NCBI
|
|
33
|
Cho H, Seo Y, Loke KM, Kim SW, Oh SM, Kim
JH, Soh J, Kim HS, Lee H, Kim J, et al: Cancer-Stimulated CAFs
enhance monocyte differentiation and protumoral TAM Activation via
IL6 and GM-CSF secretion. Clin Cancer Res. 24:5407–5421. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Najafi M, Farhood B and Mortezaee K:
Extracellular matrix (ECM) stiffness and degradation as cancer
drivers. J Cell Biochem. 120:2782–2790. 2019. View Article : Google Scholar
|
|
35
|
Ueshima E, Fujimori M, Kodama H, Felsen D,
Chen J, Durack JC, Solomon SB, Coleman JA and Srimathveeravalli G:
Macrophage-secreted TGF-β1 contributes to fibroblast
activation and ureteral stricture after ablation injury. Am J
Physiol Renal Physiol. 317:F52–F64. 2019. View Article : Google Scholar
|
|
36
|
Li G, Jin F, Du J, He Q, Yang B and Luo P:
Macrophage-secreted TSLP and MMP9 promote bleomycin-induced
pulmonary fibrosis. Toxicol Appl Pharmacol. 366:10–16. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hashimoto O, Yoshida M, Koma Y, Yanai T,
Hasegawa D, Kosaka Y, Nishimura N and Yokozaki H: Collaboration of
cancer-associated fibroblasts and tumour-associated macrophages for
neuroblastoma development. J Pathol. 240:211–223. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Takahashi H, Sakakura K, Kudo T, Toyoda M,
Kaira K, Oyama T and Chikamatsu K: Cancer-associated fibroblasts
promote an immunosuppressive microenvironment through the induction
and accumulation of protumoral macrophages. Oncotarget.
8:8633–8647. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang M, Su Z and Amoah Barnie P: Crosstalk
among colon cancer-derived exosomes, fibroblast-derived exosomes,
and macrophage phenotypes in colon cancer metastasis. Int
Immunopharmacol. 81:1062982020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li Y, Wang X, Ma X, Liu C, Wu J and Sun C:
Natural polysaccharides and their derivates: A promising natural
adjuvant for tumor immunotherapy. Front Pharmacol. 12:6218132021.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kishton RJ, Sukumar M and Restifo NP:
Metabolic Regulation of T cell longevity and function in tumor
immunotherapy. Cell Metab. 26:94–109. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Walsh AJ, Mueller KP, Tweed K, Jones I,
Walsh CM, Piscopo NJ, Niemi NM, Pagliarini DJ, Saha K and Skala MC:
Classification of T-cell activation via autofluorescence lifetime
imaging. Nat Biomed Eng. 5:77–88. 2021. View Article : Google Scholar :
|
|
43
|
Erlandsson A, Carlsson J, Lundholm M, Fält
A, Andersson SO, Andrén O and Davidsson S: M2 macrophages and
regulatory T cells in lethal prostate cancer. Prostate. 79:363–369.
2019. View Article : Google Scholar :
|
|
44
|
Liu C, Chikina M, Deshpande R, Menk AV,
Wang T, Tabib T, Brunazzi EA, Vignali KM, Sun M, Stolz DB, et al:
Treg cells promote the SREBP1-dependent metabolic fitness of
tumor-promoting macrophages via repression of CD8+ T
cell-derived interferon-γ. Immunity. 51:381–397.e6. 2019.
View Article : Google Scholar
|
|
45
|
Wu Q, Zhou W, Yin S, Zhou Y, Chen T, Qian
J, Su R, Hong L, Lu H, Zhang F, et al: Blocking triggering receptor
expressed on myeloid cells-1-positive tumor-associated macrophages
induced by hypoxia reverses immunosuppression and anti-programmed
cell death ligand 1 resistance in liver cancer. Hepatology.
70:198–214. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
La Fleur L, Botling J, He F, Pelicano C,
Zhou C, He C, Palano G, Mezheyeuski A, Micke P, Ravetch JV, et al:
Targeting MARCO and IL37R on immunosuppressive macrophages in lung
cancer blocks regulatory T cells and supports cytotoxic lymphocyte
function. Cancer Res. 81:956–967. 2021. View Article : Google Scholar
|
|
47
|
Zhou J, Li X, Wu X, Zhang T, Zhu Q and
Wang X, Wang H, Wang K, Lin Y and Wang X: Exosomes released from
tumor-associated macrophages transfer miRNAs That Induce a
Treg/Th17 cell imbalance in epithelial ovarian cancer. Cancer
Immunol Res. 6:1578–1592. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang D, Yang L, Yue D, Cao L, Li L, Wang
D, Ping Y, Shen Z, Zheng Y, Wang L and Zhang Y: Macrophage-derived
CCL22 promotes an immunosuppressive tumor microenvironment via IL-8
in malignant pleural effusion. Cancer Lett. 452:244–253. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li L, Han L, Sun F, Zhou J, Ohaegbulam KC,
Tang X, Zang X, Steinbrecher KA, Qu Z and Xiao G: NF-κB RelA
renders tumor-associated macrophages resistant to and capable of
directly suppressing CD8+ T cells for tumor promotion.
Oncoimmunology. 7:e14352502018. View Article : Google Scholar
|
|
50
|
Fujimori D, Kinoshita J, Yamaguchi T,
Nakamura Y, Gunjigake K, Ohama T, Sato K, Yamamoto M, Tsukamoto T,
Nomura S, et al: Established fibrous peritoneal metastasis in an
immunocompetent mouse model similar to clinical immune
microenvironment of gastric cancer. BMC Cancer. 20:10142020.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hu B, Wang Z, Zeng H, Qi Y, Chen Y, Wang
T, Wang J, Chang Y, Bai Q, Xia Y, et al: Blockade of
DC-SIGN+ Tumor-Associated macrophages reactivates
antitumor immunity and improves immunotherapy in muscle-invasive
bladder cancer. Cancer Res. 80:1707–1719. 2020.PubMed/NCBI
|
|
52
|
Śledzińska A, Vila de Mucha M, Bergerhoff
K, Hotblack A, Demane DF, Ghorani E, Akarca AU, Marzolini MAV,
Solomon I, Vargas FA, et al: Regulatory T cells restrain
interleukin-2- and Blimp-1-dependent acquisition of cytotoxic
function by CD4+ T cells. Immunity. 52:151–166.e6. 2020.
View Article : Google Scholar
|
|
53
|
Eisel D, Das K, Dickes E, König R, Osen W
and Eichmüller SB: Cognate interaction with CD4+ T cells
instructs tumor-associated macrophages to acquire M1-Like
phenotype. Front Immunol. 10:2192019. View Article : Google Scholar
|
|
54
|
Bogen B, Fauskanger M, Haabeth OA and
Tveita A: CD4+ T cells indirectly kill tumor cells via
induction of cytotoxic macrophages in mouse models. Cancer Immunol
Immunother. 68:1865–1873. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Nakayama T, Hirahara K, Onodera A, Endo Y,
Hosokawa H, Shinoda K, Tumes DJ and Okamoto Y: Th2 cells in health
and disease. Annu Rev Immunol. 35:53–84. 2017. View Article : Google Scholar
|
|
56
|
Shirabe K, Mano Y, Muto J, Matono R,
Motomura T, Toshima T, Takeishi K, Uchiyama H, Yoshizumi T,
Taketomi A, et al: Role of tumor-associated macrophages in the
progression of hepatocellular carcinoma. Surg Today. 42:1–7. 2012.
View Article : Google Scholar
|
|
57
|
Fu C and Jiang A: Dendritic cells and CD8
T cell immunity in tumor microenvironment. Front Immunol.
9:30592018. View Article : Google Scholar
|
|
58
|
Gardner A and Ruffell B: Dendritic cells
and cancer immunity. Trends Immunol. 37:855–865. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Verneau J, Sautés-Fridman C and Sun CM:
Dendritic cells in the tumor microenvironment: Prognostic and
theranostic impact. Semin Immunol. 48:1014102020. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Chaib M, Chauhan SC and Makowski L: Friend
or foe? Recent strategies to target myeloid cells in cancer. Front
Cell Dev Biol. 8:3512020. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zhang L, Li Z, Skrzypczynska KM, Fang Q,
Zhang W, O'Brien SA, He Y, Wang L, Zhang Q, Kim A, et al:
Single-cell analyses inform mechanisms of myeloid-targeted
therapies in colon cancer. Cell. 181442–459. (29)2020. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Dammeijer F, Lievense LA, Kaijen-Lambers
ME, van Nimwegen M, Bezemer K, Hegmans JP, van Hall T, Hendriks RW
and Aerts JG: Depletion of tumor-associated macrophages with a
CSF-1R kinase inhibitor enhances antitumor immunity and survival
induced by DC immunotherapy. Cancer Immunol Res. 5:535–546. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Ruffell B, Chang-Strachan D, Chan V,
Rosenbusch A, Ho CM, Pryer N, Daniel D, Hwang ES, Rugo HS and
Coussens LM: Macrophage IL-10 blocks CD8+ T cell-dependent
responses to chemotherapy by suppressing IL-12 expression in
intratumoral dendritic cells. Cancer Cell. 26:623–637. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Llopiz D, Ruiz M, Silva L, Repáraz D,
Aparicio B, Egea J, Lasarte JJ, Redin E, Calvo A, Angel M, et al:
Inhibition of adjuvant-induced TAM receptors potentiates cancer
vaccine immunogenicity and therapeutic efficacy. Cancer Lett.
499:279–289. 2021. View Article : Google Scholar :
|
|
65
|
Meza Guzman LG, Keating N and Nicholson
SE: Natural killer cells: Tumor surveillance and signaling. Cancers
(Basel). 12:9522020. View Article : Google Scholar
|
|
66
|
Krneta T, Gillgrass A, Poznanski S, Chew
M, Lee AJ, Kolb M and Ashkar AA: M2-polarized and tumor-associated
macrophages alter NK cell phenotype and function in a
contact-dependent manner. J Leukoc Biol. 101:285–295. 2017.
View Article : Google Scholar
|
|
67
|
Bellora F, Castriconi R, Dondero A,
Reggiardo G, Moretta L, Mantovani A, Moretta A and Bottino C: The
interaction of human natural killer cells with either unpolarized
or polarized macrophages results in different functional outcomes.
Proc Natl Acad Sci USA. 107:21659–21664. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Eisinger S, Sarhan D, Boura VF,
Ibarlucea-Benitez I, Tyystjärvi S, Oliynyk G, Arsenian-Henriksson
M, Lane D, Wikström SL, Kiessling R, et al: Targeting a scavenger
receptor on tumor-associated macrophages activates tumor cell
killing by natural killer cells. Proc Natl Acad Sci USA.
117:32005–32016. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Sprinzl MF, Reisinger F, Puschnik A,
Ringelhan M, Ackermann K, Hartmann D, Schiemann M, Weinmann A,
Galle PR, Schuchmann M, et al: Sorafenib perpetuates cellular
anticancer effector functions by modulating the crosstalk between
macrophages and natural killer cells. Hepatology. 57:2358–2368.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Kim J and Bae JS: Tumor-associated
macrophages and neutrophils in tumor microenvironment. Mediators
Inflamm. 2016:60581472016. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Kim IS, Gao Y, Welte T, Wang H, Liu J,
Janghorban M, Sheng K, Niu Y, Goldstein A, Zhao N, et al:
Immuno-subtyping of breast cancer reveals distinct myeloid cell
profiles and immunotherapy resistance mechanisms. Nat Cell Biol.
21:1113–1126. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Braza MS, Conde P, Garcia M, Cortegano I,
Brahmachary M, Pothula V, Fay F, Boros P, Werner SA, Ginhoux F, et
al: Neutrophil derived CSF1 induces macrophage polarization and
promotes transplantation tolerance. Am J Transplant. 18:1247–1255.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Fridlender ZG, Sun J, Kim S, Kapoor V,
Cheng G, Ling L, Worthen GS and Albelda SM: Polarization of
tumor-associated neutrophil phenotype by TGF-beta: 'N1' versus 'N2'
TAN. Cancer Cell. 16:183–194. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Andzinski L, Kasnitz N, Stahnke S, Wu CF,
Gereke M, von Köckritz-Blickwede M, Schilling B, Brandau S, Weiss S
and Jablonska J: Type I IFNs induce anti-tumor polarization of
tumor associated neutrophils in mice and human. Int J Cancer.
138:1982–1993. 2016. View Article : Google Scholar
|
|
75
|
Ye L, Zhang T, Kang Z, Guo G, Sun Y, Lin
K, Huang Q, Shi X, Ni Z, Ding N, et al: Tumor-infiltrating immune
cells act as a marker for prognosis in colorectal cancer. Front
Immunol. 10:23682019. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zhou Z, Wang P, Sun R, Li J, Hu Z, Xin H,
Luo C, Zhou J, Fan J and Zhou S: Tumor-associated neutrophils and
macrophages interaction contributes to intrahepatic
cholangiocarcinoma progression by activating STAT3. J Immunother
Cancer. 9:e0019462021. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Zhou SL, Zhou ZJ, Hu ZQ, Huang XW, Wang Z,
Chen EB, Fan J, Cao Y, Dai Z and Zhou J: Tumor-associated
neutrophils recruit macrophages and T-regulatory cells to promote
progression of hepatocellular carcinoma and resistance to
sorafenib. Gastroenterology. 150:1646–1658.e17. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Haider P, Kral-Pointner JB, Mayer J,
Richter M, Kaun C, Brostjan C, Eilenberg W, Fischer MB, Speidl WS,
Hengstenberg C, et al: Neutrophil extracellular trap degradation by
differently polarized macrophage subsets. Arterioscler Thromb Vasc
Biol. 40:2265–2278. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Marichal T, Tsai M and Galli SJ: Mast
cells: Potential positive and negative roles in tumor biology.
Cancer Immunol Res. 1:269–279. 2013. View Article : Google Scholar
|
|
80
|
Khazaie K, Blatner NR, Khan MW, Gounari F,
Gounaris E, Dennis K, Bonertz A, Tsai FN, Strouch MJ, Cheon E, et
al: The significant role of mast cells in cancer. Cancer Metastasis
Rev. 30:45–60. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Khan MW, Keshavarzian A, Gounaris E,
Melson JE, Cheon EC, Blatner NR, Chen ZE, Tsai FN, Lee G, Ryu H, et
al: PI3K/AKT signaling is essential for communication between
tissue-infiltrating mast cells, macrophages, and epithelial cells
in colitis-induced cancer. Clin Cancer Res. 19:2342–2354. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Galli SJ, Borregaard N and Wynn TA:
Phenotypic and functional plasticity of cells of innate immunity:
Macrophages, mast cells and neutrophils. Nat Immunol. 12:1035–1044.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Taskinen M, Karjalainen-Lindsberg ML and
Leppä S: Prognostic influence of tumor-infiltrating mast cells in
patients with follicular lymphoma treated with rituximab and CHOP.
Blood. 111:4664–4667. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Tan SY, Fan Y, Luo HS, Shen ZX, Guo Y and
Zhao LJ: Prognostic significance of cell infiltrations of
immunosurveillance in colorectal cancer. World J Gastroenterol.
11:1210–1214. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Attramadal CG, Kumar S, Gao J, Boysen ME,
Halstensen TS and Bryne M: Low mast cell density predicts poor
prognosis in oral squamous cell carcinoma and reduces survival in
head and neck squamous cell carcinoma. Anticancer Res.
36:5499–5506. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Tataroğlu C, Kargi A, Ozkal S, Eşrefoğlu N
and Akkoçlu A: Association of macrophages, mast cells and
eosinophil leukocytes with angiogenesis and tumor stage in
non-small cell lung carcinomas (NSCLC). Lung Cancer. 43:47–54.
2004. View Article : Google Scholar
|
|
87
|
Peng SH, Deng H, Yang JF, Xie PP, Li C, Li
H and Feng DY: Significance and relationship between infiltrating
inflammatory cell and tumor angiogenesis in hepatocellular
carcinoma tissues. World J Gastroenterol. 11:6521–6524. 2005.
View Article : Google Scholar
|
|
88
|
Affara NI, Ruffell B, Medler TR, Gunderson
AJ, Johansson M, Bornstein S, Bergsland E, Steinhoff M, Li Y, Gong
Q, et al: B cells regulate macrophage phenotype and response to
chemotherapy in squamous carcinomas. Cancer Cell. 25:809–821. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Wong SC, Puaux AL, Chittezhath M, Shalova
I, Kajiji TS, Wang X, Abastado JP, Lam KP and Biswas SK: Macrophage
polarization to a unique phenotype driven by B cells. Eur J
Immunol. 40:2296–2307. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Zhou M, Li W, Wen Z, Sheng Y, Ren H, Dong
H, Cao M, Hu HM and Wang LX: Macrophages enhance tumor-derived
autophagosomes (DRibbles)-induced B cells activation by TLR4/MyD88
and CD40/CD40L. Exp Cell Res. 331:320–330. 2015. View Article : Google Scholar
|
|
91
|
Lykken JM and Tedder TF: The tumor
microenvironment regulates CD19 and CD20 immunotherapy for
lymphoma. Cancer J. 21:351–356. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Dahal LN, Dou L, Hussain K, Liu R, Earley
A, Cox KL, Murinello S, Tracy I, Forconi F, Steele AJ, et al: STING
activation reverses lymphoma-mediated resistance to antibody
immunotherapy. Cancer Res. 77:3619–3631. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Sawa-Wejksza K and Kandefer-Szerszeń M:
Tumor-associated macrophages as target for antitumor therapy. Arch
Immunol Ther Exp (Warsz). 66:97–111. 2018. View Article : Google Scholar
|
|
94
|
Wang Y, Zhang Q, Chen Y, Liang CL, Liu H,
Qiu F and Dai Z: Antitumor effects of immunity-enhancing
traditional Chinese medicine. Biomed Pharmacother. 121:1095702020.
View Article : Google Scholar
|
|
95
|
He J, Yin P and Xu K: Effect and molecular
mechanisms of traditional Chinese medicine on tumor targeting
tumor-associated macrophages. Drug Des Devel Ther. 14:907–919.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Guerriero JL: Macrophages: The road less
traveled, changing anticancer therapy. Trends Mol Med. 24:472–489.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Li H, Li L, Mei H, Pan G, Wang X, Huang X,
Wang T, Jiang Z, Zhang L and Sun L: Antitumor properties of
triptolide: Phenotype regulation of macrophage differentiation.
Cancer Biol Ther. 21:178–188. 2020. View Article : Google Scholar :
|
|
98
|
Jia X, Yu F, Wang J, Iwanowycz S, Saaoud
F, Wang Y, Hu J, Wang Q and Fan D: Emodin suppresses pulmonary
metastasis of breast cancer accompanied with decreased macrophage
recruitment and M2 polarization in the lungs. Breast Cancer Res
Treat. 148:291–302. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Li H, Huang N, Zhu W, Wu J, Yang X, Teng
W, Tian J, Fang Z, Luo Y, Chen M and Li Y: Modulation the crosstalk
between tumor-associated macrophages and non-small cell lung cancer
to inhibit tumor migration and invasion by ginsenoside Rh2. BMC
Cancer. 18:5792018. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Yang Y, Sun M, Yao W, Wang F, Li X, Wang
W, Li J, Gao Z, Qiu L, You R, et al: Compound kushen injection
relieves tumor-associated macrophage-mediated immunosuppression
through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib.
J Immunother Cancer. 8:e0003172020. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Wang L, Wu W, Zhu X, Ng W, Gong C, Yao C,
Ni Z, Yan X, Fang C and Zhu S: The Ancient Chinese decoction
Yu-Ping-Feng Suppresses Orthotopic lewis lung cancer tumor growth
through increasing M1 macrophage polarization and CD4(+) T cell
cytotoxicity. Front Pharmacol. 10:13332019. View Article : Google Scholar
|
|
102
|
Wang S, Ma L, Wang Z, He H, Chen H, Duan
Z, Li Y, Si Q, Chuang TH, Chen C and Luo Y: Lactate dehydrogenase-A
(LDH-A) preserves cancer stemness and recruitment of
tumor-associated macrophages to promote breast cancer progression.
Front Oncol. 11:6544522021. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Laviron M and Boissonnas A: Ontogeny of
tumor-associated macrophages. Front Immunol. 10:17992019.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Mantovani A, Marchesi F, Malesci A, Laghi
L and Allavena P: Tumour-associated macrophages as treatment
targets in oncology. Nat Rev Clin Oncol. 14:399–416. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Qian BZ, Li J, Zhang H, Kitamura T, Zhang
J, Campion LR, Kaiser EA, Snyder LA and Pollard JW: CCL2 recruits
inflammatory monocytes to facilitate breast-tumour metastasis.
Nature. 475:222–225. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Chen C, Yao X, Xu Y, Zhang Q, Wang H, Zhao
L, Wen G, Liu Y, Jing L and Sun X: Dahuang Zhechong Pill suppresses
colorectal cancer liver metastasis via ameliorating exosomal CCL2
primed pre-metastatic niche. J Ethnopharmacol. 238:1118782019.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Wu CY, Cherng JY, Yang YH, Lin CL, Kuan
FC, Lin YY, Lin YS, Shu LH, Cheng YC, Liu HT, et al: Danshen
improves survival of patients with advanced lung cancer and
targeting the relationship between macrophages and lung cancer
cells. Oncotarget. 8:90925–90947. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Wu X, Schulte BC, Zhou Y, Haribhai D,
Mackinnon AC, Plaza JA, Williams CB and Hwang ST: Depletion of
M2-like tumor-associated macrophages delays cutaneous T-cell
lymphoma development in vivo. J Invest Dermatol. 134:2814–2822.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Zeisberger SM, Odermatt B, Marty C,
Zehnder-Fjällman AH, Ballmer-Hofer K and Schwendener RA:
Clodronate-liposome-mediated depletion of tumour-associated
macrophages: A new and highly effective antiangiogenic therapy
approach. Br J Cancer. 95:272–281. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Baert T, Vankerckhoven A, Riva M, Van
Hoylandt A, Thirion G, Holger G, Mathivet T, Vergote I and
Coosemans A: Myeloid derived suppressor cells: Key drivers of
immunosuppression in ovarian cancer. Front Immunol. 10:12732019.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Etzerodt A, Tsalkitzi K, Maniecki M,
Damsky W, Delfini M, Baudoin E, Moulin M, Bosenberg M, Graversen
JH, Auphan-Anezin N, et al: Specific targeting of CD163+ TAMs
mobilizes inflammatory monocytes and promotes T cell-mediated tumor
regression. J Exp Med. 216:2394–2411. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Scott EM, Jacobus EJ, Lyons B, Frost S,
Freedman JD, Dyer A, Khalique H, Taverner WK, Carr A, Champion BR,
et al: Bi- and tri-valent T cell engagers deplete tumour-associated
macrophages in cancer patient samples. J Immunother Cancer.
7:3202019. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Galletti G, Caligaris-Cappio F and
Bertilaccio MT: B cells and macrophages pursue a common path toward
the development and progression of chronic lymphocytic leukemia.
Leukemia. 30:2293–2301. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Deci MB, Ferguson SW, Scatigno SL and
Nguyen J: Modulating macrophage polarization through CCR2
inhibition and multivalent engagement. Mol Pharm. 15:2721–2731.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Bonapace L, Coissieux MM, Wyckoff J, Mertz
KD, Varga Z, Junt T and Bentires-Alj M: Cessation of CCL2
inhibition accelerates breast cancer metastasis by promoting
angiogenesis. Nature. 515:130–133. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Fujiwara T, Yakoub MA, Chandler A, Christ
AB, Yang G, Ouerfelli O, Rajasekhar VK, Yoshida A, Kondo H, Hata T,
et al: CSF1/CSF1R signaling inhibitor pexidartinib (PLX3397)
reprograms tumor-associated macrophages and stimulates T-cell
infiltration in the sarcoma microenvironment. Mol Cancer Ther.
20:1388–1399. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Sluijter M, van der Sluis TC, van der
Velden PA, Versluis M, West BL, van der Burg SH and van Hall T:
Inhibition of CSF-1R supports T-cell mediated melanoma therapy.
PLoS One. 9:e1042302014. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Atzori MG, Ceci C, Ruffini F, Trapani M,
Barbaccia ML, Tentori L, D'Atri S, Lacal PM and Graziani G: Role of
VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor
vemurafenib. J Cell Mol Med. 24:465–475. 2020. View Article : Google Scholar
|
|
119
|
Linde N, Lederle W, Depner S, van Rooijen
N, Gutschalk CM and Mueller MM: Vascular endothelial growth
factor-induced skin carcinogenesis depends on recruitment and
alternative activation of macrophages. J Pathol. 227:17–28. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Huang Z, Gan J, Long Z, Guo G, Shi X, Wang
C, Zang Y, Ding Z, Chen J, Zhang J and Dong L: Targeted delivery of
let-7b to reprogramme tumor-associated macrophages and tumor
infiltrating dendritic cells for tumor rejection. Biomaterials.
90:72–84. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Wu L, Zhang X, Zheng L, Zhao H, Yan G,
Zhang Q, Zhou Y, Lei J, Zhang J, Wang J, et al: RIPK3 orchestrates
fatty acid metabolism in tumor-associated macrophages and
hepatocarcinogenesis. Cancer Immunol Res. 8:710–721. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Yu Q, Wang Y, Dong L, He Y, Liu R, Yang Q,
Cao Y, Wang Y, Jia A, Bi Y and Liu G: Regulations of Glycolytic
activities on macrophages functions in tumor and infectious
inflammation. Front Cell Infect Microbiol. 10:2872020. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Baer C, Squadrito ML, Laoui D, Thompson D,
Hansen SK, Kiialainen A, Hoves S, Ries CH, Ooi CH and De Palma M:
Suppression of microRNA activity amplifies IFN-γ-induced macrophage
activation and promotes anti-tumour immunity. Nat Cell Biol.
18:790–802. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Andersen MN, Etzerodt A, Graversen JH,
Holthof LC, Moestrup SK, Hokland M and Møller HJ: STAT3 inhibition
specifically in human monocytes and macrophages by CD163-targeted
corosolic acid-containing liposomes. Cancer Immunol Immunother.
68:489–502. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Shi C, Liu T, Guo Z, Zhuang R, Zhang X and
Chen X: Reprogramming Tumor-associated macrophages by
nanoparticle-based reactive oxygen species photogeneration. Nano
Lett. 18:7330–7342. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Zhang W, Cao S, Liang S, Tan CH, Luo B, Xu
X and Saw PE: Differently charged super-paramagnetic iron oxide
nanoparticles preferentially induced M1-like phenotype of
macrophages. Front Bioeng Biotechnol. 8:5372020. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Shan H, Dou W, Zhang Y and Qi M: Targeted
ferritin nanoparticle encapsulating CpG oligodeoxynucleotides
induces tumor-associated macrophage M2 phenotype polarization into
M1 phenotype and inhibits tumor growth. Nanoscale. 12:22268–22280.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Bhattacharya U, Gutter-Kapon L, Kan T,
Boyango I, Barash U, Yang SM, Liu J, Gross-Cohen M, Sanderson RD,
Shaked Y, et al: Heparanase and chemotherapy synergize to drive
macrophage activation and enhance tumor growth. Cancer Res.
80:57–68. 2020. View Article : Google Scholar :
|
|
129
|
Halbrook CJ, Pontious C, Kovalenko I,
Lapienyte L, Dreyer S, Lee HJ, Thurston G, Zhang Y, Lazarus J,
Sajjakulnukit P, et al: Macrophage-released pyrimidines inhibit
gemcitabine therapy in pancreatic cancer. Cell Metab.
29:1390–1399.e6. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Buchholz SM, Goetze RG, Singh SK,
Ammer-Herrmenau C, Richards FM, Jodrell DI, Buchholz M, Michl P,
Ellenrieder V, Hessmann E and Neesse A: Depletion of macrophages
improves therapeutic response to gemcitabine in murine pancreas
cancer. Cancers (Basel). 12:19782020. View Article : Google Scholar
|
|
131
|
Liu Q, Wu H, Li Y, Zhang R, Kleeff J,
Zhang X, Cui M, Liu J, Li T, Gao J, et al: Combined blockade of
TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic
cancer by modulating tumor microenvironment. Cancer Immunol
Immunother. 69:1477–1492. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Baghdadi M, Wada H, Nakanishi S, Abe H,
Han N, Putra WE, Endo D, Watari H, Sakuragi N, Hida Y, et al:
Chemotherapy-induced IL34 enhances immunosuppression by
tumor-associated macrophages and mediates survival of
chemoresistant lung cancer cells. Cancer Res. 76:6030–6042. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Salvagno C, Ciampricotti M, Tuit S, Hau
CS, van Weverwijk A, Coffelt SB, Kersten K, Vrijland K, Kos K, Ulas
T, et al: Therapeutic targeting of macrophages enhances
chemotherapy efficacy by unleashing type I interferon response. Nat
Cell Biol. 21:511–521. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Wanderley CW, Colón DF, Luiz JPM, Oliveira
FF, Viacava PR, Leite CA, Pereira JA, Silva CM, Silva CR, Silva RL,
et al: Paclitaxel reduces tumor growth by reprogramming
tumor-associated macrophages to an M1 profile in a TLR4-dependent
manner. Cancer Res. 78:5891–5900. 2018.PubMed/NCBI
|
|
135
|
Jin H, He Y, Zhao P, Hu Y, Tao J, Chen J
and Huang Y: Targeting lipid metabolism to overcome EMT-associated
drug resistance via integrin β3/FAK pathway and tumor-associated
macrophage repolarization using legumain-activatable delivery.
Theranostics. 9:265–278. 2019. View Article : Google Scholar :
|
|
136
|
Inoue T, Fujishima S, Ikeda E, Yoshie O,
Tsukamoto N, Aiso S, Aikawa N, Kubo A, Matsushima K and Yamaguchi
K: CCL22 and CCL17 in rat radiation pneumonitis and in human
idiopathic pulmonary fibrosis. Eur Respir J. 24:49–56. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Shiao SL, Ruffell B, DeNardo DG, Faddegon
BA, Park CC and Coussens LM: TH2-polarized CD4(+) T cells and
macrophages limit efficacy of radiotherapy. Cancer Immunol Res.
3:518–525. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Jarosz-Biej M, Smolarczyk R, Cichoń T,
Drzyzga A, Czapla J, Urbaś Z, Pilny E, Matuszczak S and Wojcieszek
P: Brachytherapy in a Single dose of 10Gy as an 'in situ'
Vaccination. Int J Mol Sci. 21:45852020. View Article : Google Scholar
|
|
139
|
Teresa Pinto A, Laranjeiro Pinto M,
Patrícia Cardoso A, Monteiro C, Teixeira Pinto M, Filipe Maia A,
Castro P, Figueira R, Monteiro A, Marques M, et al: Ionizing
radiation modulates human macrophages towards a pro-inflammatory
phenotype preserving their pro-invasive and pro-angiogenic
capacities. Sci Rep. 6:187652016. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Rödel F, Frey B, Manda K, Hildebrandt G,
Hehlgans S, Keilholz L, Seegenschmiedt MH, Gaipl US and Rödel C:
Immunomodulatory properties and molecular effects in inflammatory
diseases of low-dose x-irradiation. Front Oncol. 2:1202012.
View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Seifert L, Werba G, Tiwari S, Giao Ly NN,
Nguy S, Alothman S, Alqunaibit D, Avanzi A, Daley D, Barilla R, et
al: Radiation therapy induces macrophages to suppress T-cell
responses against pancreatic tumors in mice. Gastroenterology.
150:1659–1672.e5. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Jones KI, Tiersma J, Yuzhalin AE,
Gordon-Weeks AN, Buzzelli J, Im JH and Muschel RJ: Radiation
combined with macrophage depletion promotes adaptive immunity and
potentiates checkpoint blockade. EMBO Mol Med. 10:e93422018.
View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Candas-Green D, Xie B, Huang J, Fan M,
Wang A, Menaa C, Zhang Y, Zhang L, Jing D, Azghadi S, et al: Dual
blockade of CD47 and HER2 eliminates radioresistant breast cancer
cells. Nat Commun. 11:45912020. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Meziani L, Mondini M, Petit B, Boissonnas
A, Thomas de Montpreville V, Mercier O, Vozenin MC and Deutsch E:
CSF1R inhibition prevents radiation pulmonary fibrosis by depletion
of interstitial macrophages. Eur Respir J. 51:17021202018.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Riley RS, June CH, Langer R and Mitchell
MJ: Delivery technologies for cancer immunotherapy. Nat Rev Drug
Discov. 18:175–196. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Kruger S, Ilmer M, Kobold S, Cadilha BL,
Endres S, Ormanns S, Schuebbe G, Renz BW, D'Haese JG, Schloesser H,
et al: Advances in cancer immunotherapy 2019-latest trends. J Exp
Clin Cancer Res. 38:2682019. View Article : Google Scholar
|
|
147
|
Peranzoni E, Lemoine J, Vimeux L, Feuillet
V, Barrin S, Kantari-Mimoun C, Bercovici N, Guérin M, Biton J,
Ouakrim H, et al: Macrophages impede CD8 T cells from reaching
tumor cells and limit the efficacy of anti-PD-1 treatment. Proc
Natl Acad Sci USA. 115:E4041–E4050. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Gordon SR, Maute RL, Dulken BW, Hutter G,
George BM, McCracken MN, Gupta R, Tsai JM, Sinha R, Corey D, et al:
PD-1 expression by tumour-associated macrophages inhibits
phagocytosis and tumour immunity. Nature. 545:495–499. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Klichinsky M, Ruella M, Shestova O, Lu XM,
Best A, Zeeman M, Schmierer M, Gabrusiewicz K, Anderson NR, Petty
NE, et al: Human chimeric antigen receptor macrophages for cancer
immunotherapy. Nat Biotechnol. 38:947–953. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Advani R, Flinn I, Popplewell L, Forero A,
Bartlett NL, Ghosh N, Kline J, Roschewski M, LaCasce A, Collins GP,
et al: CD47 blockade by Hu5F9-G4 and rituximab in Non-Hodgkin's
lymphoma. N Engl J Med. 379:1711–1721. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Rao L, Zhao SK, Wen C, Tian R, Lin L, Cai
B, Sun Y, Kang F, Yang Z, He L, et al: Activating
macrophage-mediated cancer immunotherapy by genetically edited
nanoparticles. Adv Mater. 32:e20048532020. View Article : Google Scholar : PubMed/NCBI
|
